CO5130021A1 - Reduccion de inactivacion de surfactantes en terapia pulmo nar con surfactantes , - Google Patents
Reduccion de inactivacion de surfactantes en terapia pulmo nar con surfactantes ,Info
- Publication number
- CO5130021A1 CO5130021A1 CO99052859A CO99052859A CO5130021A1 CO 5130021 A1 CO5130021 A1 CO 5130021A1 CO 99052859 A CO99052859 A CO 99052859A CO 99052859 A CO99052859 A CO 99052859A CO 5130021 A1 CO5130021 A1 CO 5130021A1
- Authority
- CO
- Colombia
- Prior art keywords
- surfactants
- inactivation
- pulmo
- nar
- therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Polímeros hidrofílicos no iónicos ó carbohidratos son administrados ya sea individualmente o en conexión con surfactantes pulmonares terapéuticamente activos para el tratamiento de una variedad de dolencias pulmonares. Incluidas entre las actividades de estos agentes está su capacidad para reducir la inactivación de surfactantes por sustancias endógenas presentes en los pulmones.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/138,435 US6180142B1 (en) | 1998-08-21 | 1998-08-21 | Reduction of surfactant inactivation in pulmonary surfactant therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5130021A1 true CO5130021A1 (es) | 2002-02-27 |
Family
ID=22482003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO99052859A CO5130021A1 (es) | 1998-08-21 | 1999-08-20 | Reduccion de inactivacion de surfactantes en terapia pulmo nar con surfactantes , |
Country Status (4)
Country | Link |
---|---|
US (1) | US6180142B1 (es) |
AU (1) | AU5679899A (es) |
CO (1) | CO5130021A1 (es) |
WO (1) | WO2000010550A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT977577E (pt) * | 1997-02-17 | 2007-02-28 | Altana Pharma Ag | Composições para o tratamento de ards ou irds contendo 3-(ciclopropilmetoxi)-n- (3,5-dicloro-4-piridinil)-4-(difluorometoxi) benzamina e tensioactivo pulmonar. |
US8933032B2 (en) | 1998-10-20 | 2015-01-13 | Children's Hospital Medical Center | Surfactant protein D for the treatment of disorders associated with lung injury |
US20030221199A1 (en) * | 1998-10-20 | 2003-11-27 | Whitsett Jeffrey A. | Surfactant protein D for the prevention and diagnosis of pulmonary emphysema |
US6838428B2 (en) * | 1998-10-20 | 2005-01-04 | Children's Hospital Medical Center | Surfactant protein D for the prevention and diagnosis of pulmonary emphysema |
WO2001058423A1 (en) * | 2000-02-11 | 2001-08-16 | Altana Pharma Ag | Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases |
DE60217060T2 (de) * | 2002-03-01 | 2007-06-21 | Chiesi Farmaceutici S.P.A. | Pharmazeutische Zusammensetzungen, die Lungensurfactants und ein Polymyxin umfassen und verbesserte Oberflächenspannung-senkende Eigenschaften haben |
US7538090B1 (en) | 2004-05-21 | 2009-05-26 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Exogenous surfactant protein B mimic |
WO2006128025A2 (en) * | 2005-05-23 | 2006-11-30 | Children's Hospital Medical Center | Regulatory proteins in lung repair and treatment of lung disease |
WO2008121811A2 (en) * | 2007-03-29 | 2008-10-09 | National Jewish Medical And Research Center | Surfactant lipids, compositions thereof, and uses thereof |
US9345716B2 (en) | 2010-12-10 | 2016-05-24 | Indian Institute Of Technology, Bombay | Protein free surfactant composition for pulmonary diseases and a process for preparing the same |
US20120220531A1 (en) | 2011-02-04 | 2012-08-30 | Cincinnati Children's Hospital Medical Center | Surfactant protein d for the treatment of disorders associated with lung injury |
US9693990B2 (en) | 2011-10-14 | 2017-07-04 | The Trustees Of The Stevens Institute Of Technology | Use of rhodamine dyes to reduce alveolar surface tension |
US9504796B2 (en) | 2011-10-14 | 2016-11-29 | The Trustees Of The Stevens Institute Of Technology | Reducing ventilator-induced lung injury |
JPWO2016104627A1 (ja) * | 2014-12-24 | 2017-10-05 | 宇部興産株式会社 | 肺組織由来の細胞培養上清液 |
US10391151B2 (en) | 2015-06-29 | 2019-08-27 | The Trustees Of The Stevens Institute Of Technology | Dilute surfactant or isolated surfactant protein solution for the reduction of surface tension in the lung |
CA3032457A1 (en) | 2016-08-12 | 2018-02-15 | Purdue Research Foundation | Polymer lung surfactants |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4312860A (en) * | 1980-10-24 | 1982-01-26 | Regents Of The University Of California | Lung surfactant compositions |
US4826821A (en) * | 1985-06-26 | 1989-05-02 | The Regents Of The University Of California | Lung surfactant compositions |
US5110806A (en) * | 1985-06-26 | 1992-05-05 | The Regents Of The University Of California | Lung surfactant compositions |
US5108759A (en) * | 1987-04-01 | 1992-04-28 | Ranney David F | Endothelial envelopment drug carriers |
US5885974A (en) * | 1994-12-06 | 1999-03-23 | Michael M. Danielov | Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor |
US6524557B1 (en) | 1994-12-22 | 2003-02-25 | Astrazeneca Ab | Aerosol formulations of peptides and proteins |
WO1997035882A1 (en) | 1996-03-27 | 1997-10-02 | Ortho Pharmaceutical Corporation | Lyophilized pulmonary surfactant peptide compositions |
US5855913A (en) * | 1997-01-16 | 1999-01-05 | Massachusetts Instite Of Technology | Particles incorporating surfactants for pulmonary drug delivery |
GB9717905D0 (en) | 1997-08-22 | 1997-10-29 | Univ Aston | Lipid-containing compositions and uses thereof |
-
1998
- 1998-08-21 US US09/138,435 patent/US6180142B1/en not_active Expired - Fee Related
-
1999
- 1999-08-18 AU AU56798/99A patent/AU5679899A/en not_active Abandoned
- 1999-08-18 WO PCT/US1999/018880 patent/WO2000010550A2/en active Application Filing
- 1999-08-20 CO CO99052859A patent/CO5130021A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU5679899A (en) | 2000-03-14 |
WO2000010550A2 (en) | 2000-03-02 |
US6180142B1 (en) | 2001-01-30 |
WO2000010550A3 (en) | 2000-06-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5130021A1 (es) | Reduccion de inactivacion de surfactantes en terapia pulmo nar con surfactantes , | |
TR200102308T2 (tr) | Yüzey etkinliğine sahip yapay peptidler ve bunların yapay yüzey aktif maddelerin hazırlanmasında kullanımı | |
NO2014010I1 (no) | Radium 223 salt slik som Radium 223 diklorid | |
AR027391A1 (es) | Composiciones farmaceuticas de toxina botulinica | |
MX9504415A (es) | Eteres antivirales de isoesteres de sustrato de proteasa de aspartato. | |
NO963447L (no) | Transdermale, terapeutiske systemer som inneholder seksualsteroider | |
CY1116463T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
ES2170141T3 (es) | 4-aminoderivados del acido micofenolico con actividad inmunosupresora. | |
BR0109779A (pt) | Soluções moleculares hidrofìlicas dispersas de carvedilol | |
ES2194720T3 (es) | Enzimas para el tratamiento de diabetes mellitus tipo i. | |
ES2089260T3 (es) | Composicion topica que contiene lisinato de cetoprofeno. | |
BR0115162A (pt) | Tratamentos antitumorais eficazes | |
DK1401422T3 (da) | Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf | |
BR9814299A (pt) | Aminobiguanidas e o seu uso para desinfetarlentes de contato e preservar composiçõesfarmacêuticas | |
AR019699A1 (es) | Composicion farmaceutica para el tratamiento de disfuncion de la evacuacion y uso de la misma para la preparacion de un agente terapeutico | |
AR015744A1 (es) | Uso de dexmedetomidina para sedacion en terapia intensiva | |
BR0016831A (pt) | Composição terapêutica e lente de contato impregnada pela mesma | |
ES2236525T3 (es) | Antarticina-nf3 para el tratamiento y re-epitelizacion. | |
NO983090L (no) | Terapeutiske forbindelser | |
NO965483L (no) | Dinukleosid-5',5'-pyrofosfater | |
BR0307317A (pt) | Tratamento de combinação para infartação miocardial aguda | |
DE50113974D1 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
EA199700150A1 (ru) | КОМБИНИРОВАННОЕ ЛЕЧЕНИЕ ПО ПОВОДУ ВИЧ ИНФЕКЦИИ С ИСПОЛЬЗОВАНИЕМ ИНГИБИТОРА ПРОТЕАЗЫ ВИЧ ИНДИНАВИРА И ИНГИБИТОРА ОБРАТНОЙ ТРАНСКРИПТАЗЫ 3TC, НЕОБЯЗАТЕЛЬНО СОВМЕСТНО С AZT, ddI ИЛИ ddC | |
ITMI922742A0 (it) | Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
MX9304636A (es) | Metodos de tratamiento terapeutico y anestesico y preparaciones para ellos. |